Click for best price

Transmucosal Drug Delivery Market Size, Share 2022

Market Analysis and Insights: Global Transmucosal Drug Delivery Market

The global Transmucosal Drug Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transmucosal Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transmucosal Drug Delivery market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transmucosal Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transmucosal Drug Delivery market.

Global Transmucosal Drug Delivery Scope and Market Size

Transmucosal Drug Delivery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transmucosal Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Passive Transdermal Drug Delivery

Active Transdermal Drug Delivery

Segment by Application

Hospital

Clinic

Others

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

3M Pharmaceuticals

Acrux Limited

ALZA Corporation

Antares Pharma, Inc.

Apricus BioSciences, Inc

Aveva Drug Delivery Systems

Corium International, Inc

DURECT Corporation

Generex Biotechnology Corporation

Inovio Pharmaceuticals, Inc.

Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)

MedPharm LTD

Mylan, Inc.

Nemaura Pharma Ltd

Nitto Denko Corporation

Noven Pharmaceuticals, Inc.

Pantec Biosolutions AG

Tapemark

tesa Labtec GmbH

TEVA Pharmaceutical Industries Ltd.

Zosano Pharma

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Transmucosal Drug Delivery product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Transmucosal Drug Delivery, with price, sales, revenue, and global market share of Transmucosal Drug Delivery from 2019 to 2022.

Chapter 3, the Transmucosal Drug Delivery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Transmucosal Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Transmucosal Drug Delivery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Transmucosal Drug Delivery.

Chapter 13, 14, and 15, to describe Transmucosal Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Transmucosal Drug Delivery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Transmucosal Drug Delivery Market Research Report 2022
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	115 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Passive Transdermal Drug Delivery
1.2.3 Active Transdermal Drug Delivery
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Market Perspective (2017-2028)
2.2 Transmucosal Drug Delivery Growth Trends by Region
2.2.1 Transmucosal Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Transmucosal Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Transmucosal Drug Delivery Market Dynamics
2.3.1 Transmucosal Drug Delivery Industry Trends
2.3.2 Transmucosal Drug Delivery Market Drivers
2.3.3 Transmucosal Drug Delivery Market Challenges
2.3.4 Transmucosal Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transmucosal Drug Delivery Players by Revenue
3.1.1 Global Top Transmucosal Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transmucosal Drug Delivery Revenue
3.4 Global Transmucosal Drug Delivery Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2021
3.5 Transmucosal Drug Delivery Key Players Head office and Area Served
3.6 Key Players Transmucosal Drug Delivery Product Solution and Service
3.7 Date of Enter into Transmucosal Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Transmucosal Drug Delivery Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Transmucosal Drug Delivery Market Size (2017-2028)
6.2 North America Transmucosal Drug Delivery Market Size by Country (2017-2022)
6.3 North America Transmucosal Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Market Size (2017-2028)
7.2 Europe Transmucosal Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Transmucosal Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transmucosal Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Transmucosal Drug Delivery Market Size (2017-2028)
9.2 Latin America Transmucosal Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Transmucosal Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transmucosal Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 3M Pharmaceuticals
11.1.1 3M Pharmaceuticals Company Detail
11.1.2 3M Pharmaceuticals Business Overview
11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
11.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.1.5 3M Pharmaceuticals Recent Development
11.2 Acrux Limited
11.2.1 Acrux Limited Company Detail
11.2.2 Acrux Limited Business Overview
11.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
11.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.2.5 Acrux Limited Recent Development
11.3 ALZA Corporation
11.3.1 ALZA Corporation Company Detail
11.3.2 ALZA Corporation Business Overview
11.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
11.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.3.5 ALZA Corporation Recent Development
11.4 Antares Pharma, Inc.
11.4.1 Antares Pharma, Inc. Company Detail
11.4.2 Antares Pharma, Inc. Business Overview
11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
11.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.4.5 Antares Pharma, Inc. Recent Development
11.5 Apricus BioSciences, Inc
11.5.1 Apricus BioSciences, Inc Company Detail
11.5.2 Apricus BioSciences, Inc Business Overview
11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
11.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.5.5 Apricus BioSciences, Inc Recent Development
11.6 Aveva Drug Delivery Systems
11.6.1 Aveva Drug Delivery Systems Company Detail
11.6.2 Aveva Drug Delivery Systems Business Overview
11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
11.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.6.5 Aveva Drug Delivery Systems Recent Development
11.7 Corium International, Inc
11.7.1 Corium International, Inc Company Detail
11.7.2 Corium International, Inc Business Overview
11.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
11.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.7.5 Corium International, Inc Recent Development
11.8 DURECT Corporation
11.8.1 DURECT Corporation Company Detail
11.8.2 DURECT Corporation Business Overview
11.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
11.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.8.5 DURECT Corporation Recent Development
11.9 Generex Biotechnology Corporation
11.9.1 Generex Biotechnology Corporation Company Detail
11.9.2 Generex Biotechnology Corporation Business Overview
11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
11.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.9.5 Generex Biotechnology Corporation Recent Development
11.10 Inovio Pharmaceuticals, Inc.
11.10.1 Inovio Pharmaceuticals, Inc. Company Detail
11.10.2 Inovio Pharmaceuticals, Inc. Business Overview
11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.10.5 Inovio Pharmaceuticals, Inc. Recent Development
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Detail
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
11.12 MedPharm LTD
11.12.1 MedPharm LTD Company Detail
11.12.2 MedPharm LTD Business Overview
11.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
11.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.12.5 MedPharm LTD Recent Development
11.13 Mylan, Inc.
11.13.1 Mylan, Inc. Company Detail
11.13.2 Mylan, Inc. Business Overview
11.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
11.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.13.5 Mylan, Inc. Recent Development
11.14 Nemaura Pharma Ltd
11.14.1 Nemaura Pharma Ltd Company Detail
11.14.2 Nemaura Pharma Ltd Business Overview
11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
11.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.14.5 Nemaura Pharma Ltd Recent Development
11.15 Nitto Denko Corporation
11.15.1 Nitto Denko Corporation Company Detail
11.15.2 Nitto Denko Corporation Business Overview
11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
11.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.15.5 Nitto Denko Corporation Recent Development
11.16 Noven Pharmaceuticals, Inc.
11.16.1 Noven Pharmaceuticals, Inc. Company Detail
11.16.2 Noven Pharmaceuticals, Inc. Business Overview
11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.16.5 Noven Pharmaceuticals, Inc. Recent Development
11.17 Pantec Biosolutions AG
11.17.1 Pantec Biosolutions AG Company Detail
11.17.2 Pantec Biosolutions AG Business Overview
11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
11.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.17.5 Pantec Biosolutions AG Recent Development
11.18 Tapemark
11.18.1 Tapemark Company Detail
11.18.2 Tapemark Business Overview
11.18.3 Tapemark Transmucosal Drug Delivery Introduction
11.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.18.5 Tapemark Recent Development
11.19 tesa Labtec GmbH
11.19.1 tesa Labtec GmbH Company Detail
11.19.2 tesa Labtec GmbH Business Overview
11.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
11.19.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.19.5 tesa Labtec GmbH Recent Development
11.20 TEVA Pharmaceutical Industries Ltd.
11.20.1 TEVA Pharmaceutical Industries Ltd. Company Detail
11.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
11.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development
11.21 Zosano Pharma
11.21.1 Zosano Pharma Company Detail
11.21.2 Zosano Pharma Business Overview
11.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
11.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.21.5 Zosano Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Passive Transdermal Drug Delivery
Table 3. Key Players of Active Transdermal Drug Delivery
Table 4. Global Transmucosal Drug Delivery Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Transmucosal Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Transmucosal Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Transmucosal Drug Delivery Market Share by Region (2017-2022)
Table 8. Global Transmucosal Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Transmucosal Drug Delivery Market Share by Region (2023-2028)
Table 10. Transmucosal Drug Delivery Market Trends
Table 11. Transmucosal Drug Delivery Market Drivers
Table 12. Transmucosal Drug Delivery Market Challenges
Table 13. Transmucosal Drug Delivery Market Restraints
Table 14. Global Transmucosal Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Transmucosal Drug Delivery Market Share by Players (2017-2022)
Table 16. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery as of 2021)
Table 17. Ranking of Global Top Transmucosal Drug Delivery Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Transmucosal Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Transmucosal Drug Delivery Product Solution and Service
Table 21. Date of Enter into Transmucosal Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Transmucosal Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Transmucosal Drug Delivery Revenue Market Share by Type (2017-2022)
Table 25. Global Transmucosal Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Transmucosal Drug Delivery Revenue Market Share by Type (2023-2028)
Table 27. Global Transmucosal Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Transmucosal Drug Delivery Revenue Market Share by Application (2017-2022)
Table 29. Global Transmucosal Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Transmucosal Drug Delivery Revenue Market Share by Application (2023-2028)
Table 31. North America Transmucosal Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Transmucosal Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Transmucosal Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Transmucosal Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Transmucosal Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Transmucosal Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 41. 3M Pharmaceuticals Company Detail
Table 42. 3M Pharmaceuticals Business Overview
Table 43. 3M Pharmaceuticals Transmucosal Drug Delivery Product
Table 44. 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 45. 3M Pharmaceuticals Recent Development
Table 46. Acrux Limited Company Detail
Table 47. Acrux Limited Business Overview
Table 48. Acrux Limited Transmucosal Drug Delivery Product
Table 49. Acrux Limited Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 50. Acrux Limited Recent Development
Table 51. ALZA Corporation Company Detail
Table 52. ALZA Corporation Business Overview
Table 53. ALZA Corporation Transmucosal Drug Delivery Product
Table 54. ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 55. ALZA Corporation Recent Development
Table 56. Antares Pharma, Inc. Company Detail
Table 57. Antares Pharma, Inc. Business Overview
Table 58. Antares Pharma, Inc. Transmucosal Drug Delivery Product
Table 59. Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 60. Antares Pharma, Inc. Recent Development
Table 61. Apricus BioSciences, Inc Company Detail
Table 62. Apricus BioSciences, Inc Business Overview
Table 63. Apricus BioSciences, Inc Transmucosal Drug Delivery Product
Table 64. Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 65. Apricus BioSciences, Inc Recent Development
Table 66. Aveva Drug Delivery Systems Company Detail
Table 67. Aveva Drug Delivery Systems Business Overview
Table 68. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product
Table 69. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 70. Aveva Drug Delivery Systems Recent Development
Table 71. Corium International, Inc Company Detail
Table 72. Corium International, Inc Business Overview
Table 73. Corium International, Inc Transmucosal Drug Delivery Product
Table 74. Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 75. Corium International, Inc Recent Development
Table 76. DURECT Corporation Company Detail
Table 77. DURECT Corporation Business Overview
Table 78. DURECT Corporation Transmucosal Drug Delivery Product
Table 79. DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 80. DURECT Corporation Recent Development
Table 81. Generex Biotechnology Corporation Company Detail
Table 82. Generex Biotechnology Corporation Business Overview
Table 83. Generex Biotechnology Corporation Transmucosal Drug Delivery Product
Table 84. Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 85. Generex Biotechnology Corporation Recent Development
Table 86. Inovio Pharmaceuticals, Inc. Company Detail
Table 87. Inovio Pharmaceuticals, Inc. Business Overview
Table 88. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
Table 89. Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 90. Inovio Pharmaceuticals, Inc. Recent Development
Table 91. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Detail
Table 92. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
Table 93. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug DeliveryProduct
Table 94. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 95. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
Table 96. MedPharm LTD Company Detail
Table 97. MedPharm LTD Business Overview
Table 98. MedPharm LTD Transmucosal Drug DeliveryProduct
Table 99. MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 100. MedPharm LTD Recent Development
Table 101. Mylan, Inc. Company Detail
Table 102. Mylan, Inc. Business Overview
Table 103. Mylan, Inc. Transmucosal Drug DeliveryProduct
Table 104. Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 105. Mylan, Inc. Recent Development
Table 106. Nemaura Pharma Ltd Company Detail
Table 107. Nemaura Pharma Ltd Business Overview
Table 108. Nemaura Pharma Ltd Transmucosal Drug DeliveryProduct
Table 109. Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 110. Nemaura Pharma Ltd Recent Development
Table 111. Nitto Denko Corporation Company Detail
Table 112. Nitto Denko Corporation Business Overview
Table 113. Nitto Denko Corporation Transmucosal Drug DeliveryProduct
Table 114. Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 115. Nitto Denko Corporation Recent Development
Table 116. Noven Pharmaceuticals, Inc. Company Detail
Table 117. Noven Pharmaceuticals, Inc. Business Overview
Table 118. Noven Pharmaceuticals, Inc. Transmucosal Drug DeliveryProduct
Table 119. Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 120. Noven Pharmaceuticals, Inc. Recent Development
Table 121. Pantec Biosolutions AG Company Detail
Table 122. Pantec Biosolutions AG Business Overview
Table 123. Pantec Biosolutions AG Transmucosal Drug DeliveryProduct
Table 124. Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 125. Pantec Biosolutions AG Recent Development
Table 126. Tapemark Company Detail
Table 127. Tapemark Business Overview
Table 128. Tapemark Transmucosal Drug DeliveryProduct
Table 129. Tapemark Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 130. Tapemark Recent Development
Table 131. tesa Labtec GmbH Company Detail
Table 132. tesa Labtec GmbH Business Overview
Table 133. tesa Labtec GmbH Transmucosal Drug DeliveryProduct
Table 134. tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 135. tesa Labtec GmbH Recent Development
Table 136. TEVA Pharmaceutical Industries Ltd. Company Detail
Table 137. TEVA Pharmaceutical Industries Ltd. Business Overview
Table 138. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug DeliveryProduct
Table 139. TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 140. TEVA Pharmaceutical Industries Ltd. Recent Development
Table 141. Zosano Pharma Company Detail
Table 142. Zosano Pharma Business Overview
Table 143. Zosano Pharma Transmucosal Drug DeliveryProduct
Table 144. Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 145. Zosano Pharma Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transmucosal Drug Delivery Market Share by Type: 2021 VS 2028
Figure 2. Passive Transdermal Drug Delivery Features
Figure 3. Active Transdermal Drug Delivery Features
Figure 4. Global Transmucosal Drug Delivery Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Transmucosal Drug Delivery Report Years Considered
Figure 9. Global Transmucosal Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Transmucosal Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Transmucosal Drug Delivery Market Share by Region: 2021 VS 2028
Figure 12. Global Transmucosal Drug Delivery Market Share by Players in 2021
Figure 13. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2021
Figure 15. North America Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Transmucosal Drug Delivery Market Share by Country (2017-2028)
Figure 17. United States Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Transmucosal Drug Delivery Market Share by Country (2017-2028)
Figure 21. Germany Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Transmucosal Drug Delivery Market Share by Region (2017-2028)
Figure 29. China Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Transmucosal Drug Delivery Market Share by Country (2017-2028)
Figure 37. Mexico Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Transmucosal Drug Delivery Market Share by Country (2017-2028)
Figure 41. Turkey Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Transmucosal Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. 3M Pharmaceuticals Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 44. Acrux Limited Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 45. ALZA Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 46. Antares Pharma, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 47. Apricus BioSciences, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 48. Aveva Drug Delivery Systems Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 49. Corium International, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 50. DURECT Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 51. Generex Biotechnology Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 52. Inovio Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 53. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 54. MedPharm LTD Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 55. Mylan, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 56. Nemaura Pharma Ltd Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 57. Nitto Denko Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 58. Noven Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 59. Pantec Biosolutions AG Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 60. Tapemark Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 61. tesa Labtec GmbH Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 62. TEVA Pharmaceutical Industries Ltd. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 63. Zosano Pharma Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Transmucosal Drug Delivery Market Research Report 2022